Findings on Prostate Cancer Reported by Investigators at Loyola University Medical Center (Risk of Prostate Cancer for Men With Prior Negative Biopsies Undergoing Magnetic Resonance Imaging Compared With Biopsy-naive Men: a Prospective ...)

摘要

2021 SEP 21 (NewsRx)- By a News Reporter-Staff News Editor at Disease Prevention Daily- Investigators publish new report on Oncology - Prostate Cancer. According to news reporting originating from Maywood, Illinois, by NewsRx correspondents, research stated, "Men with prior negative prostate biopsies have a lower risk of being diagnosed with prostate cancer in comparison with biopsy-naive men. However, the relative clinical utility of identified lesions on multiparametric magnetic resonance imaging (mpMRI) is uncertain between the 2 settings." Financial support for this research came from Siemens Medical Solutions USA, Inc. Our news editors obtained a quote from the research from Loyola University Medical Center, "Patients from the Prospective Loyola University mpMRI (PLUM) Prostate Biopsy Cohort (January 2015 to June 2020) were examined. The detection of any prostate cancer and clinically significant prostate cancer (Gleason score >= 3 + 4) was stratified by Prostate Imaging-Reporting and Data System (PI-RADS) scores in the prior negative and biopsy-naive settings. Multivariable logistic regression models (PLUM models) assessed predictors, and decision curve analyses were used to estimate the clinical utility of PI-RADS cutoffs relative to the models.